Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
11
|
pubmed:dateCreated |
1989-2-23
|
pubmed:abstractText |
Oligoclonal T-cells have been generated by sensitization of peripheral blood mononuclear cells from lung cancer patients to a lung cancer tumor-associated antigen (TAA). A factor similar to the antigen-specific glycoprotein factor in the serum of these cancer patients was found in the supernatant of the oligoclonal T-cells. The factor from the T-cell supernatant had specificity for lung cancer TAA and induced stimulation of normal lymphocytes of the CD8 phenotype when mixed with lung cancer TAA. Furthermore, the factor blocked the ability of lymphocytes from lung cancer patients to recognize lung cancer TAA. Both the factor from lung cancer serum and from the oligoclonal T-cells were absorbed on a lung cancer-associated antigen-coupled immunosorbent column. On FPLC-gel filtration the desorbed fractions from the immunosorbent column from both sources showed activity in the same molecular weight range, 70-90 kD. Heteroantisera raised against the factor from serum and against the factor from the oligoclonal T-cell supernatant bound about the same portion of lymphocytes from lung cancer patients as measured by immunofluorescence, while only a minor fraction of cells from patients with unrelated cancers and from healthy persons were labelled on incubation with the antisera. These results support the hypothesis that an antigen-specific factor found in serum of cancer patients is produced by antigen-stimulated T-cells, possibly of the CD8 phenotype. This putative antigen-specific suppressor factor and the tumor antigen-reactive lymphocytes of the patient seem to share similar idiotopes.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0277-5379
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
24
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1763-70
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:2463170-Antigens, Neoplasm,
pubmed-meshheading:2463170-Carcinoma, Squamous Cell,
pubmed-meshheading:2463170-Chromatography, Gel,
pubmed-meshheading:2463170-Epitopes,
pubmed-meshheading:2463170-Humans,
pubmed-meshheading:2463170-Immunologic Techniques,
pubmed-meshheading:2463170-Leukocyte Adherence Inhibition Test,
pubmed-meshheading:2463170-Lung Neoplasms,
pubmed-meshheading:2463170-Molecular Weight,
pubmed-meshheading:2463170-Suppressor Factors, Immunologic,
pubmed-meshheading:2463170-T-Lymphocytes
|
pubmed:year |
1988
|
pubmed:articleTitle |
Role of T-lymphocytes in production of a cancer-associated protein factor in serum from lung cancer patients.
|
pubmed:affiliation |
Institute for Cancer Research, Norwegian Radium Hospital, Oslo.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|